Chandana, S. R., Kelley, R. K., Finn, R. S., Dumbrava, E. E., Ikeda, M., Hamm, J. T., Grewal, J. S., Gutierrez, M., Maruki, Y., Nakajima, T. E., Ikoma, T., Weinstein, M., Mekan, S. F., Abou-Alfa, G. K. (2026). A phase 1, first-in-human, multicenter study of ZW251, a novel glypican-3 (GPC3)–targeted antibody-drug conjugate (ADC), in participants with hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps608